Key result
Lipoprotein(a) testing grows substantially over the past decade, though overall utilization remains limited.
Why the study?
What are the 10-year trends in Lipoprotein(a) testing ordering patterns in Queensland and Australia?
Observational
Yes
What are the 10-year trends in Lipoprotein(a) testing ordering patterns in Queensland and Australia?
Answers are grounded in this paper and cite their sources.
Despite substantial growth over the past decade, overall Lipoprotein(a) testing remains limited in Australia, highlighting the need for broader implementation of guideline-based testing.
Lp(a) testing has grown substantially in Queensland and Australia over the past decade, likely reflecting increased recognition of its causal role in cardiovascular disease, evolving guideline recommendations, test accessibility, and the emergence of novel therapies. However, overall testing remains limited. Broader implementation of guideline-based testing and greater clinician awareness will be critical to ensure timely identification of individuals who may benefit from available and emerging therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Bachmeier et al. (2026) conducted an observational in Cardiovascular disease. Lipoprotein(a) testing was evaluated on Lipoprotein(a) testing ordering patterns. Lipoprotein(a) testing has grown substantially in Queensland and Australia over the past decade, although overall testing remains limited.
Synapse has enriched 10 related papers. Consider them for comparative context: